Candriam announces an important leadership transition within its Thematic Global Equity platform, and related fund management changes to its healthcare strategies, including strategies investing in the biotechnology sector, life care and in the fight against cancer.

Candriam announces a strategic evolution of its Emerging Market Equity team, effective 1 February 2024.

In unserem „Engagement-Bericht 2022“ haben wir in einer Fallstudie aufgezeigt, wie wir eine themenbezogene Kampagne starten.

At Candriam, we are both more active and more demanding in our engagement activities, an attitude shared by several other investors, mostly European.

Nicolas Forest wird mit Wirkung zum 1. Mai 2023 Chief Investment Officer (CIO) bei Candriam. Zuvor war Nicolas Forest seit 2013 Global Head of Fixed Income bei dem globalen, auf nachhaltiges und verantwortungsbewusstes Investieren konzentrierten Multi-Asset-Manager.

Wir freuen uns, Ihnen mitteilen zu können, dass unser CEO, Naïm Abou-Jaoudé, zum CEO von New York Life Investment Management (NYLIM) ernannt wurde.

In the context of the European measures taken against Russia and Belarus, management companies are particularly concerned by the provisions of Article 5f of the amended EU Regulation 833/2014 for Russia and Regulation 398/2022 of 9 March 2022 for Belarus.

First and foremost, our thoughts are with the Ukrainian people at this terrible and uncertain time. Candriam and its employees are deeply saddened by the events we are seeing unfold, and deplore the human tragedy this brings.